Biopharma News

Jul 03, 2018
By BioPharm International Editors
The pharma major intends to spinoff Alcon as a stand-alone eye-care devices company.
Jul 03, 2018
By BioPharm International Editors
Biogen will pay Samsung BioLogics approximately $700 million to increase its stake in Samsung Bioepis to approximately 49.9%.
Jun 29, 2018
By BioPharm International Editors
Sanofi will sell Zentiva, its European generics business, to private equity investor Advent International.
Jun 28, 2018
By BioPharm International Editors
The companies will partner to develop T-cell therapies for cancer.
Jun 25, 2018
By BioPharm International Editors
GW Research’s Epidiolex, which treats two forms of epilepsy, receives FDA’s approval; spurs FDA reminders about unapproved products.
Jun 22, 2018
By BioPharm International Editors
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
Jun 20, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Roche’s personalized healthcare strategy.
Jun 20, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Sanofi’s R&D strategy with Ablynx’s nanobody technology platform.
Jun 20, 2018
By BioPharm International Editors
The company has resubmitted a biologics license application to FDA for its proposed biosimilar to Roche’s Herceptin.
Jun 13, 2018
By BioPharm International Editors
Alexion Pharmaceuticals and Complement Pharma will partner to develop a preclinical C6 complement inhibitor to treat neurodegenerative disorders.
native1_300x100
lorem ipsum